5-114362471-C-CCTG
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PM4_SupportingBS1_SupportingBS2
The NM_021614.4(KCNN2):c.350_352dupGCT(p.Cys117dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 444,272 control chromosomes in the GnomAD database, including 37 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.015 ( 22 hom., cov: 33)
Exomes 𝑓: 0.012 ( 15 hom. )
Consequence
KCNN2
NM_021614.4 disruptive_inframe_insertion
NM_021614.4 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.77
Genes affected
KCNN2 (HGNC:6291): (potassium calcium-activated channel subfamily N member 2) Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. The protein encoded by this gene is activated before membrane hyperpolarization and is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene is a member of the KCNN family of potassium channel genes. The encoded protein is an integral membrane protein that forms a voltage-independent calcium-activated channel with three other calmodulin-binding subunits. Alternate splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_021614.4. Strenght limited to Supporting due to length of the change: 1aa.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0145 (2211/152178) while in subpopulation NFE AF= 0.0172 (1166/67956). AF 95% confidence interval is 0.0163. There are 22 homozygotes in gnomad4. There are 1054 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 2211 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNN2 | NM_021614.4 | c.350_352dupGCT | p.Cys117dup | disruptive_inframe_insertion | 1/8 | ENST00000673685.1 | NP_067627.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNN2 | ENST00000673685.1 | c.350_352dupGCT | p.Cys117dup | disruptive_inframe_insertion | 1/8 | NM_021614.4 | ENSP00000501239.1 | |||
KCNN2 | ENST00000512097.10 | c.548_550dupGCT | p.Cys183dup | disruptive_inframe_insertion | 6/13 | 5 | ENSP00000427120.4 |
Frequencies
GnomAD3 genomes AF: 0.0145 AC: 2208AN: 152074Hom.: 22 Cov.: 33
GnomAD3 genomes
AF:
AC:
2208
AN:
152074
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0123 AC: 3601AN: 292094Hom.: 15 Cov.: 0 AF XY: 0.0120 AC XY: 1822AN XY: 151908
GnomAD4 exome
AF:
AC:
3601
AN:
292094
Hom.:
Cov.:
0
AF XY:
AC XY:
1822
AN XY:
151908
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0145 AC: 2211AN: 152178Hom.: 22 Cov.: 33 AF XY: 0.0142 AC XY: 1054AN XY: 74392
GnomAD4 genome
AF:
AC:
2211
AN:
152178
Hom.:
Cov.:
33
AF XY:
AC XY:
1054
AN XY:
74392
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with or without variable movement or behavioral abnormalities Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The observed inframe insertion variant c.350_352dup(p.Cys117dup) in KCNN2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.350_352dup has 1.7% allele frequency in gnomAD Exomes. This variant p.Cys117dup causes duplication of amino acid Cysteine at postion 117. For these reasons, this variant has been classified as Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at